Is Gilead Sciences a Good Coronavirus Stock to Buy?
Last May, Gilead Sciences (NASDAQ: GILD) became one of the hottest stocks around after advancing the world's first coronavirus treatment, Veklury (then called remdesivir) to market. Shares of the large-cap blue-chip biotech soared over 30% after the news, but enthusiasm for Veklury has largely cooled off since. Not only has Gilead stock lost all of its gains, but it is now down slightly from a year ago.
Those looking for hot coronavirus stocks will likely be disappointed in Gilead. But there are several other factors that make it a good investment nonetheless.
Image source: Getty Images.
Source Fool.com
